Edwards Lifesciences Corporation Common Stock

Financials

İşletme faaliyetlerinden elde edilen nakit -127.5 M280.4 M290.2 M573.7 M450.9 M43.8 M 1.36 B Yatırım faaliyetlerinden elde edilen nakit -576.7 M85.3 M-172.1 M-427.8 M-198.3 M-92.8 M -891 M Finansman faaliyetlerinden elde edilen nakit 28.6 M-258 M52.7 M-740.1 M-11.4 M-451.2 M -1.15 B Serbest nakit akışı -127.5 M280.4 M240.9 M516.2 M353.5 M-21.1 M 1.09 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

EW

Financials

Edwards Lifesciences Corporation Common Stock

Haberler

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

Edwards Lifesciences CVP Donald Bobo Jr. 2 milyon dolarlık hisse sattı

Edwards Lifesciences hissesi 87,89 dolarla zirve yaptı

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Edwards Lifesciences CVP Wayne Markowitz 47.279 dolarlık hisse sattı

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)

Edwards Lifesciences TAVR başkan yardımcısı 170.160 dolar değerinde hisse sattı

Edwards Lifesciences yeni CFO’sunu atadı

Top Research Reports for Philip Morris, Honeywell & Starbucks